Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 1
1948 1
1952 2
1958 1
1966 1
1967 1
1972 1
1975 2
1984 1
1985 2
1986 1
1988 2
1989 1
1990 2
1991 3
1992 2
1993 1
1994 5
1996 2
1998 2
1999 3
2000 2
2001 2
2002 2
2004 1
2005 1
2007 3
2008 8
2009 5
2010 6
2011 3
2012 2
2013 1
2014 1
2015 2
2016 1
2017 4
2018 8
2019 7
2020 9
2021 9
2022 6
2023 5
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.
Sarkisian SR Jr, Ang RE, Lee AM, Berdahl JP, Heersink SB, Burden JH, Doan LV, Stephens KG, Kothe AC, Usner DW, Katz LJ, Navratil T; GC-010 Travoprost Intraocular Implant Investigators. Sarkisian SR Jr, et al. Ophthalmology. 2024 Sep;131(9):1021-1032. doi: 10.1016/j.ophtha.2024.02.022. Epub 2024 Feb 27. Ophthalmology. 2024. PMID: 38423216 Clinical Trial.
August consultation #4.
Brubaker JW. Brubaker JW. J Cataract Refract Surg. 2018 Aug;44(8):1051-1052. doi: 10.1016/j.jcrs.2018.07.008. J Cataract Refract Surg. 2018. PMID: 30115284 No abstract available.
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.
Davis AJ, Brooijmans N, Brubaker JD, Stevison F, LaBranche TP, Albayya F, Fleming P, Hodous BL, Kim JL, Kim S, Lobbardi R, Palmer M, Sheets MP, Vassiliadis J, Wang R, Williams BD, Wilson D, Xu L, Zhu XJ, Bouchard K, Hunter JW, Graul C, Greenblatt E, Hussein A, Lyon M, Russo J, Stewart R, Dorsch M, Guzi TJ, Kadambi V, Lengauer C, Garner AP. Davis AJ, et al. Among authors: brubaker jd. Sci Transl Med. 2024 May 29;16(749):eabp8334. doi: 10.1126/scitranslmed.abp8334. Epub 2024 May 29. Sci Transl Med. 2024. PMID: 38809966
Difficult decisions, filtration surgery, and the heartbreak of the numerator.
Samuelson TW, De Francesco T, Ahmed IIK, Gedde SJ, Paranjpe VR, Singh K, Brubaker JW, Grover DS, Fellman RL, Zhang AD, Barton K. Samuelson TW, et al. Among authors: brubaker jw. J Cataract Refract Surg. 2024 Jan 1;50(1):97-103. doi: 10.1097/j.jcrs.0000000000001366. J Cataract Refract Surg. 2024. PMID: 38133650
Visual outcomes of combined cataract surgery and minimally invasive glaucoma surgery.
Sarkisian SR Jr, Radcliffe N, Harasymowycz P, Vold S, Patrianakos T, Zhang A, Herndon L, Brubaker J, Moster R, Francis B; ASCRS Glaucoma Clinical Committee. Sarkisian SR Jr, et al. Among authors: brubaker j. J Cataract Refract Surg. 2020 Oct;46(10):1422-1432. doi: 10.1097/j.jcrs.0000000000000317. J Cataract Refract Surg. 2020. PMID: 32657904 Review.
Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer.
Eno MS, Brubaker JD, Campbell JE, De Savi C, Guzi TJ, Williams BD, Wilson D, Wilson K, Brooijmans N, Kim J, Özen A, Perola E, Hsieh J, Brown V, Fetalvero K, Garner A, Zhang Z, Stevison F, Woessner R, Singh J, Timsit Y, Kinkema C, Medendorp C, Lee C, Albayya F, Zalutskaya A, Schalm S, Dineen TA. Eno MS, et al. Among authors: brubaker jd. J Med Chem. 2022 Jul 28;65(14):9662-9677. doi: 10.1021/acs.jmedchem.2c00704. Epub 2022 Jul 15. J Med Chem. 2022. PMID: 35838760 Free PMC article.
130 results